Actively Recruiting

Phase 1
Age: 18Years - 55Years
All Genders
Healthy Volunteers
NCT07156201

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

Led by Actio Biosciences, Inc. · Updated on 2025-11-26

74

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This first in human trial will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses, multiple ascending doses, and fed and fasted doses of ABS-1230 given orally compared with placebo in adult healthy participants.

CONDITIONS

Official Title

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

Who Can Participate

Age: 18Years - 55Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 55 years, inclusive
  • Body mass index between 18 and 32 kg/m2
  • Medically healthy with no clinically significant medical history or abnormal physical exam, vital signs, ECG, or laboratory tests at screening
  • Male and female participants must use adequate birth control and agree not to donate sperm or eggs for specified periods in the protocol
Not Eligible

You will not qualify if you...

  • Positive test for HIV, HBV, or HCV
  • History of cancer except treated basal cell carcinoma, squamous cell carcinoma, or carcinoma in situ of the cervix
  • History of alcoholism or recreational drug use within 2 years or positive alcohol or tobacco test at screening
  • For female participants, pregnancy, breastfeeding, or seeking to become pregnant during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Scientia Clinical Research

Sydney, New South Wales, Australia

Actively Recruiting

Loading map...

Research Team

A

Actio Biosciences, Inc.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years | DecenTrialz